The effect of acetaminophen (four grams a day for three consecutive days) on hepatic tests in alcoholic patients – a multicenter randomized study
Open Access
- 30 May 2007
- journal article
- research article
- Published by Springer Nature in BMC Medicine
- Vol. 5 (1), 13
- https://doi.org/10.1186/1741-7015-5-13
Abstract
Background: Hepatic failure has been associated with reported therapeutic use of acetaminophen by alcoholic patients. The highest risk period for alcoholic patients is immediately after discontinuation of alcohol intake. This period exhibits the largest increase in CYP2E1 induction and lowest glutathione levels. Our hypothesis was that common liver tests would be unaffected by administration of the maximum recommended daily dosage of acetaminophen for 3 consecutive days to newly-abstinent alcoholic subjects.Methods: Adult alcoholic subjects entering two alcohol detoxification centers were enrolled in a prospective double-blind, randomized, placebo-controlled trial. Subjects were randomized to acetaminophen, 4 g/day, or placebo for 3 consecutive days. The study had 95% probability of detecting a 15 IU/L difference in serum ALT.Results: A total of 443 subjects were enrolled: 308 (258 completed) received acetaminophen and 135 subjects (114 completed) received placebo. Study groups did not differ in demographics, alcohol consumption, nutritional status or baseline laboratory assessments. The peak mean ALT activity was 57 ± 45 IU/L and 55 ± 48 IU/L in the acetaminophen and placebo groups, respectively. Subgroup analyses for subjects presenting with an elevated ALT, subjects fulfilling a diagnosis of alcoholic hepatitis and subjects attaining a peak ALT greater than 200 IU/L showed no statistical difference between the acetaminophen and control groups. The one participant developing an increased international normalized ratio was in the placebo group.Conclusion: Alcoholic patients treated with the maximum recommended daily dose of acetaminophen for 3 consecutive days did not develop increases in serum transaminase or other measures of liver injury. Treatment of pain or fever for 3 days with acetaminophen appears safe in newly-abstinent alcoholic patients, such as those presenting for acute medical care.Keywords
This publication has 36 references indexed in Scilit:
- Acetaminophen‐induced acute liver failureHepatology, 2005
- Evaluation of Abnormal Liver-Enzyme Results in Asymptomatic PatientsNew England Journal of Medicine, 2000
- Decrease in Cytochrome P4502E1 as Assessed by the Rate of Chlorzoxazone Hydroxylation in Alcoholics during the Withdrawal PhaseAlcohol, Clinical and Experimental Research, 1995
- Induction of Cytochrome P450 2E1 during Chronic Ethanol Exposure Occurs via Transcription of the Cyp 2E1 Gene When Blood Alcohol Concentrations Are HighBiochemical and Biophysical Research Communications, 1993
- The Effect of Chronic Alcohol Intake on Prognosis and Outcome in Paracetamol OverdoseHuman & Experimental Toxicology, 1991
- Molecular Mechanisms of the Hepatotoxicity Caused by AcetaminophenSeminars in Liver Disease, 1990
- Glutathione deficiency in alcoholics: risk factor for paracetamol hepatotoxicity.Gut, 1988
- Depressed hepatic glutathione and increased diene conjugates in alcoholic liver diseaseDigestive Diseases and Sciences, 1983
- IS THERE A PLACE FOR CIMETIDINE OR ETHANOL IN THE TREATMENT OF PARACETAMOL POISONING?The Lancet, 1983
- Nutritional AssessmentNew England Journal of Medicine, 1982